Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cognetivity Neurosciences Ltd (OP: CGNSF ) 0.0035 UNCHANGED Streaming Delayed Price Updated: 1:01 PM EST, Nov 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cognetivity Neurosciences Ltd AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners June 08, 2023 As psychedelics and AI travel their own development paths, here are some initiatives looking at ways of enhancing the former with the latter’s help. Via Benzinga UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round October 28, 2022 A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd. Via Benzinga Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market February 08, 2022 Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression December 02, 2021 Ketamine One, a Canada-based health and wellness company focused on treatments for mental health, is teaming up with Cognetivity Neurosciences (OTCMKTS: CGNSF) for a collaborative... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
